Analysis for Science Applications International
Analysis summary
Science Applications International (SAIC) currently has a total score of 28 points, placing it in the weak range. The score is made up of Performance (28), Stability (30) and Trend (26). All three sub-scores are currently below average.
Performance scores 28 points (weak). Least weak metric: 10Y return at 112.3 %. Main drag: 3Y return at -17.9 %. This suggests stronger long-term than short-term performance.
Stability scores 30 points (weak). Best-ranked metric: max drawdown (10Y) at -46.0 %. Main drag: Sortino ratio (90d) at -0.92. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 26 points (weak). Trend signals are mostly negative right now. Least weak metric: 12M momentum at 10.4 %. Main drag: Price is about 16.0 % below SMA50.
Overall, the profile is fairly consistent across dimensions. On a metric level, max drawdown (10Y) stands out, while SMA50 distance is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Performance
Stability
FAQ
- What investor type does Science Applications International fit best in FoxScore?
- Science Applications International looks fairly balanced in FoxScore: the sub-scores are close to each other. This often fits a diversified approach — then check the metrics (e.g., drawdowns/volatility) to see if they match your risk tolerance.
- How meaningful is the available history for Science Applications International?
- Science Applications International currently has about 12.4 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.